NZ518436A - Transdermal drug delivery devices - Google Patents

Transdermal drug delivery devices

Info

Publication number
NZ518436A
NZ518436A NZ518436A NZ51843600A NZ518436A NZ 518436 A NZ518436 A NZ 518436A NZ 518436 A NZ518436 A NZ 518436A NZ 51843600 A NZ51843600 A NZ 51843600A NZ 518436 A NZ518436 A NZ 518436A
Authority
NZ
New Zealand
Prior art keywords
adhesive
devices
skin contacting
drug delivery
delivery devices
Prior art date
Application number
NZ518436A
Inventor
Steve J Dreyer
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Priority claimed from PCT/US2000/029702 external-priority patent/WO2001030316A2/en
Publication of NZ518436A publication Critical patent/NZ518436A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Abstract

Systems and devices for the transdermal delivery of the compound (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-one, 0-[3(3-methoxyphenyl)-2-propynyl]oxime are disclosed. These devices include a drug in adhesive reservoir layer and a skin contacting adhesive layer in which the skin contacting adhesive layer acts as a rate controlling membrane. These devices also include a drug in adhesive reservoir layer and a skin contacting adhesive, where a membrane is placed between the two adhesive layers. The compound is a muscarinic agonist, useful in the treatment of a variety of cognitive disorders, including Alzheimer's Disease.
NZ518436A 1999-10-28 2000-10-27 Transdermal drug delivery devices NZ518436A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16236899P 1999-10-28 1999-10-28
US69753200A 2000-10-26 2000-10-26
PCT/US2000/029702 WO2001030316A2 (en) 1999-10-28 2000-10-27 Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime

Publications (1)

Publication Number Publication Date
NZ518436A true NZ518436A (en) 2002-11-26

Family

ID=26858694

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ518436A NZ518436A (en) 1999-10-28 2000-10-27 Transdermal drug delivery devices

Country Status (12)

Country Link
EP (1) EP1229905A2 (en)
JP (1) JP2003512414A (en)
KR (1) KR20020047298A (en)
CN (1) CN1384738A (en)
CA (1) CA2388611A1 (en)
CZ (1) CZ20021496A3 (en)
HU (1) HUP0203282A3 (en)
IL (1) IL149115A0 (en)
MX (1) MXPA02004151A (en)
NO (1) NO20022013L (en)
NZ (1) NZ518436A (en)
PL (1) PL354651A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10333393A1 (en) * 2003-07-23 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system with the active ingredient pramipexole
JP4567998B2 (en) * 2004-03-22 2010-10-27 コスメディ製薬株式会社 Hydrophilic external skin pressure-sensitive adhesive composition and hydrophilic patch using hydrophilic pressure-sensitive adhesive
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner

Also Published As

Publication number Publication date
PL354651A1 (en) 2004-02-09
JP2003512414A (en) 2003-04-02
NO20022013L (en) 2002-06-28
IL149115A0 (en) 2002-11-10
NO20022013D0 (en) 2002-04-26
KR20020047298A (en) 2002-06-21
MXPA02004151A (en) 2002-10-17
EP1229905A2 (en) 2002-08-14
CN1384738A (en) 2002-12-11
CA2388611A1 (en) 2001-05-03
HUP0203282A2 (en) 2003-02-28
HUP0203282A3 (en) 2003-11-28
CZ20021496A3 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
WO1997034586A3 (en) Device and method for treating ophthalmic diseases
WO2001019406A3 (en) Amphiphilic prodrugs
AU2002236470A1 (en) Uses for medical devices having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders
CA2391808A1 (en) Method for treatment of symptoms of central nervous system disorders
CA2326804A1 (en) Compounds with activity on muscarinic receptors
WO1996010429A3 (en) Improved transdermal device having decreased delamination
AU8070298A (en) Surface coatings for catheters, direct contacting diagnostic and therapeutic devices
IS2434B (en) Spiro [1-azabicyclo [2.2.2] octane-3,2 '(3'H) -furo [2,3-b] pyridine] for use in the treatment of psychiatric disorders and cognitive disorders
WO2002058684A3 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
CA2149242A1 (en) Quinuclidine Derivative for Treatment of Inflammatory and Gastrointestinal Disorders
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
BR0111892A (en) Bis-arylsulfones
CA2368823A1 (en) Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders
WO2000033814A3 (en) Method for administering agents to the central nervous system
AU7662400A (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
AU6995700A (en) Therapeutic system containing an active substance for the application on the skin which contains at least two polymerous layers
CA2449922A1 (en) Pharmaceutical composition for therapy of interstitial cystitis
AU3086900A (en) Device for the complex treatment of disorders of the prostate
WO2001030316A3 (en) Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime
NZ518436A (en) Transdermal drug delivery devices
WO2002039997A3 (en) Ace-2 modulating compounds and use thereof
AU7291996A (en) Transdermal therapeutic system (tts) for the administration of drugs for treatment of drug dependency or drug addiction
WO1994025025A3 (en) Systems for controlled release of pilocarpine
WO2000009098A3 (en) Method for treating ocular neovascular diseases
CA2274895A1 (en) Contour of a transdermal therapeutic system

Legal Events

Date Code Title Description
PSEA Patent sealed